Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma; Carcinoma, Basal Cell Phase 2 ClinicalTrials
Melanoma Phase 1/Phase 2 ClinicalTrials
CONTENTS